Dr. Biao Xi, Principle Scientist at ACEA Biosciences receives the 2014...

Cardiac liability continues to be a major topic of concern in drug development. Dr. Biao Xi's publication entitled "Functional Cardiotoxicity Profiling and Screening Using the xCELLigence RTCA-Cardio System" is recognized for its popularity among life science authors throughout 2013.

http://ift.tt/1fzUNar